Melanoma and Other Skin Cancers
5 protocols meet the specified criteria.
-
A151804
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events -
EAY191
Molecular Analysis for Combination Therapy Choice (ComboMATCH) -
EAY191-A3
A ComboMATCH Treatment Trial: Palbociclib and Binimetinib in RAS-Mutant Cancer -
EAY191-N5
A Randomized Trial of Neratinib, A Pan-ErbB Inhibitor, Alone or in Combination with Palbociclib, A CDK4/6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and Other Solid Tumors - A ComboMATCH Treatment Trial -
R3767-ONC-22122
A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolumab In Participants with Unresectable or Metastatic Melanoma